Seattle Clinical Research Center | Seattle, WA

Research site

(Unclaimed)

Location

633 Yesler Way, Seattle, Washington, United States of America

Site insights

Top conditions

Top treatments

Elinzanetant

BAY3427080

K-304

Semaglutide

Gabapentin

BAY1817080

Desvenlafaxine

EVO756

Galantamine

LY573144

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 36 total trials

Locations recently updated

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Not yet enrolling

Acute Migraine

Drug: Placebo

Drug: Elismetrep

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide (AMAZE 7)

The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treat...

Begins enrollment in 2 months

Overweight

Obesity

Drug: Placebo (matched to zenagamtide)

Drug: Semaglutide

A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight (RESTRAIN-SUI)

The GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron work...

Enrolling

Urinary Incontinence,Stress

Drug: Placebo

Drug: Orforglipron

Status recently updated

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with plac...

Not yet enrolling

Enrolling

Migraine

Drug: Placebo

Drug: Elismetrep

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea...

Enrolling

Overweight

Obstructive Sleep Apnoea

Drug: NNC0487-0111

Drug: Placebo (matched to NNC0487-0111)

Contraceptive Efficacy Study of Ovaprene

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectivene...

Enrolling

Contraception

Device: Ovaprene

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Active, not recruiting

Women at Risk for Pregnancy

Drug: VeraCept

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD)...

Active, not recruiting

Change in Bone Mineral Density

Bone Loss

Drug: drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tablet

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain (ELARIS EM-COC)

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Active, not recruiting

Endometriosis

Drug: Elagolix

Drug: Placebo

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

The Sponsor is developing a progestin-only contraceptive transdermal system (patch).The main purpose of this study is to look at how safe the study p...

Active, not recruiting

Female Contraception

Drug: Transdermal system containing progestin

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidat...

Enrolling

Acne

Other: Placebo

Biological: Acne mRNA vaccine